Abstract |
|
Authors | Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto, Yukihiko Sugiyama |
Journal | The European respiratory journal
(Eur Respir J)
Vol. 45
Issue 5
Pg. 1382-92
(May 2015)
ISSN: 1399-3003 [Electronic] England |
PMID | 25504994
(Publication Type: Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright ©ERS 2015. |
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Enzyme Inhibitors
- Indoles
- Pyridones
- pirfenidone
- nintedanib
|
Topics |
- Aged
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, adverse effects, pharmacokinetics)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Enzyme Inhibitors
(administration & dosage, adverse effects, pharmacokinetics)
- Female
- Humans
- Idiopathic Pulmonary Fibrosis
(drug therapy)
- Indoles
(administration & dosage, adverse effects, pharmacokinetics)
- Japan
- Male
- Middle Aged
- Patient Safety
- Pyridones
(administration & dosage, adverse effects, pharmacokinetics)
- Treatment Outcome
- Vital Capacity
|